Hedge Fund - Sivik Global Healthcare
Boston Scientific Corp (BSX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $9,246,000 | 2.16% | 135,000 | $64.30 |
| 2 | 2023 - Q4 (2023-12-31) | $9,250,000 | 3.86% | 160,000 | $53.38 |
| 3 | 2023 - Q3 (2023-09-30) | $8,448,000 | 4.26% | 160,000 | $52.45 |
| 4 | 2023 - Q2 (2023-06-30) | $8,654,000 | 2.02% | 160,000 | $52.23 |
| 5 | 2023 - Q1 (2023-03-31) | $7,755,000 | 3.33% | 155,000 | $47.13 |
| 6 | 2022 - Q4 (2022-12-31) | $8,560,000 | 4.02% | 185,000 | $43.30 |
| 7 | 2022 - Q3 (2022-09-30) | $7,165,000 | 3.98% | 185,000 | $40.12 |
| 8 | 2022 - Q2 (2022-06-30) | $6,895,000 | 3.91% | 185,000 | $40.71 |
| 9 | 2022 - Q1 (2022-03-31) | $8,858,000 | 3.65% | 200,000 | $43.34 |
| 10 | 2021 - Q4 (2021-12-31) | $6,797,000 | 2.91% | 160,000 | $42.02 |
| 11 | 2021 - Q3 (2021-09-30) | $9,546,000 | 2.28% | 220,000 | $44.24 |
| 12 | 2021 - Q2 (2021-06-30) | $8,124,000 | 1.58% | 190,000 | $42.07 |
| 13 | 2021 - Q1 (2021-03-31) | $8,696,000 | 3.17% | 225,000 | $37.85 |
| 14 | 2020 - Q4 (2020-12-31) | $7,190,000 | 2.93% | 200,000 | $36.04 |
| 15 | 2020 - Q3 (2020-09-30) | $6,496,000 | 2.79% | 170,000 | $38.53 |
| 16 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $36.01 |
| 17 | 2020 - Q1 (2020-03-31) | $3,714,000 | 1.46% | 7,500 | $39.07 |
| 18 | 2019 - Q4 (2019-12-31) | $7,914,000 | 2.93% | 175,000 | $41.84 |
| 19 | 2019 - Q3 (2019-09-30) | $8,138,000 | 4.1% | 200,000 | $42.37 |
| 20 | 2019 - Q2 (2019-06-30) | $8,596,000 | 2.07% | 200,000 | $38.46 |
| 21 | 2019 - Q1 (2019-03-31) | $8,636,000 | 3.18% | 225,000 | $38.19 |
| 22 | 2018 - Q4 (2018-12-31) | $7,775,000 | 4.19% | 220,000 | $36.27 |
| 23 | 2018 - Q3 (2018-09-30) | $9,048,000 | 3.22% | 235,000 | $34.93 |
| 24 | 2018 - Q2 (2018-06-30) | $8,502,000 | 3.26% | 260,000 | $30.16 |
| 25 | 2018 - Q1 (2018-03-31) | $4,781,000 | 2.23% | 175,000 | $27.18 |
| 26 | 2017 - Q4 (2017-12-31) | $4,710,000 | 1.74% | 190,000 | $27.58 |
| 27 | 2017 - Q3 (2017-09-30) | $7,584,000 | 2.58% | 260,000 | $27.62 |
| 28 | 2017 - Q2 (2017-06-30) | $6,653,000 | 2.43% | 240,000 | $26.54 |
| 29 | 2017 - Q1 (2017-03-31) | $4,974,000 | 2.31% | 200,000 | $24.32 |
| 30 | 2016 - Q4 (2016-12-31) | $3,785,000 | 1.8% | 175,000 | $21.82 |
| 31 | 2016 - Q3 (2016-09-30) | $4,760,000 | 2.39% | 200,000 | $23.86 |
| 32 | 2016 - Q2 (2016-06-30) | $7,011,000 | 3.48% | 300,000 | $21.63 |
| 33 | 2016 - Q1 (2016-03-31) | $5,643,000 | 2.49% | 300,000 | $17.57 |
| 34 | 2015 - Q4 (2015-12-31) | $5,532,000 | 2.62% | 300,000 | $17.92 |
| 35 | 2015 - Q3 (2015-09-30) | $2,462,000 | 1.19% | 150,000 | $17.09 |
| 36 | 2015 - Q2 (2015-06-30) | $4,830,000 | 1.67% | 272,900 | $17.87 |
| 37 | 2015 - Q1 (2015-03-31) | $5,325,000 | 1.81% | 300,000 | $15.80 |
| 38 | 2014 - Q2 (2014-06-30) | $0 | 0% | 0 | $13.00 |
| 39 | 2014 - Q1 (2014-03-31) | $2,392,000 | 1.49% | 176,950 | $13.13 |
| 40 | 2013 - Q4 (2013-12-31) | $2,404,000 | 1.7% | 200,000 | $11.81 |
The displayed share prices are average quarterly stock market prices.